IAPs: Modular regulators of cell signalling

Seminars in Cell and Developmental Biology

Volumn 39, Issue , 2015, Pages 80-90

  Budhidarmo, Rhesa ^a   Day, Catherine L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

BIR; Domain; IAP; RING; Ubiquitin

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN;

ALPHA HELIX; APOPTOSIS; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; RING FINGER MOTIF; SIGNAL TRANSDUCTION; UBIQUITINATION; AMINO ACID SEQUENCE; ANIMAL; CELL FUNCTION; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT;

INTRACISTERNAL A-PARTICLES;

AMINO ACID SEQUENCE; ANIMALS; CELL PHYSIOLOGICAL PHENOMENA; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 84928203429     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.12.002     Document Type: Review

References (106)

1. Clem R.J., Fechheimer M., Miller L.K. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 1991, 254:1388-1390.
2. Crook N.E., Clem R.J., Miller L.K. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 1993, 67:2168-2174.
3. Verhagen A.M., Coulson E.J., Vaux D.L. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol 2001, 2. REVIEWS3009.
4. Hinds M.G., Norton R.S., Vaux D.L., Day C.L. Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nat Struct Biol 1999, 6:648-651.
5. Srinivasula S.M., Hegde R., Saleh A., Datta P., Shiozaki E., Chai J., et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 2001, 410:112-116.
6. Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P., Srinivasula S.M., et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 2003, 11:519-527.
7. Huang Y., Park Y.C., Rich R.L., Segal D., Myszka D.G., Wu H. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell 2001, 104:781-790.
8. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun C., Fesik S.W., et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 2001, 104:791-800.
9. Chai J., Shiozaki E., Srinivasula S.M., Wu Q., Datta P., Alnemri E.S., et al. Structural basis of caspase-7 inhibition by XIAP. Cell 2001, 104:769-780.
10. Eckelman B.P., Salvesen G.S. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 2006, 281:3254-3260.
11. Eckelman B.P., Salvesen G.S., Scott F.L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 2006, 7:988-994.
12. Du C., Fang M., Li Y., Li L., Wang X. Smac a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102:33-42.
13. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000, 102:43-53.
14. Chai J., Du C., Wu J.W., Kyin S., Wang X., Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 2000, 406:855-862.
15. Liu Z., Sun C., Olejniczak E.T., Meadows R.P., Betz S.F., Oost T., et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 2000, 408:1004-1008.
16. Wu G., Chai J., Suber T.L., Wu J.W., Du C., Wang X., et al. Structural basis of IAP recognition by Smac/DIABLO. Nature 2000, 408:1008-1012.
17. Kulathila R., Vash B., Sage D., Cornell-Kennon S., Wright K., Koehn J., et al. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9. Acta Crystallogr D 2009, 65:58-66.
18. Eckelman B.P., Drag M., Snipas S.J., Salvesen G.S. The mechanism of peptide-binding specificity of IAP BIR domains. Cell Death Differ 2008, 15:920-928.
19. Franklin M.C., Kadkhodayan S., Ackerly H., Alexandru D., Distefano M.D., Elliott L.O., et al. Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP). Biochemistry 2003, 42:8223-8231.
20. Lukacs C., Belunis C., Crowther R., Danho W., Gao L., Goggin B., et al. The structure of XIAP BIR2: understanding the selectivity of the BIR domains. Acta Crystallogr D 2013, 69:1717-1725.
21. Sweeney M.C., Wang X., Park J., Liu Y., Pei D. Determination of the sequence specificity of XIAP BIR domains by screening a combinatorial peptide library. Biochemistry 2006, 45:14740-14748.
22. Dynek J.N., Vucic D. Antagonists of IAP proteins as cancer therapeutics. Cancer Lett 2013, 332:206-214.
23. Petersen S.L., Wang L., Yalcin-Chin A., Li L., Peyton M., Minna J., et al. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 2007, 12:445-456.
24. Varfolomeev E., Blankenship J.W., Wayson S.M., Fedorova A.V., Kayagaki N., Garg P., et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007, 131:669-681.
25. Vince J.E., Wong W.W., Khan N., Feltham R., Chau D., Ahmed A.U., et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007, 131:682-693.
26. Verhagen A.M., Kratina T.K., Hawkins C.J., Silke J., Ekert P.G., Vaux D.L. Identification of mammalian mitochondrial proteins that interact with IAPs via N-terminal IAP binding motifs. Cell Death Differ 2007, 14:348-357.
27. Zhuang M., Guan S., Wang H., Burlingame A.L., Wells J.A. Substrates of IAP ubiquitin ligases identified with a designed orthogonal E3 ligase, the NEDDylator. Mol Cell 2013, 49:273-282.
28. Damgaard R.B., Fiil B.K., Speckmann C., Yabal M., zur Stadt U., Bekker-Jensen S., et al. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling. EMBO Mol Med 2013, 5:1278-1295.
29. Damgaard R.B., Nachbur U., Yabal M., Wong W.W., Fiil B.K., Kastirr M., et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell 2012, 46:746-758.
30. Vallabhapurapu S., Matsuzawa A., Zhang W., Tseng P.H., Keats J.J., Wang H., et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol 2008, 9:1364-1370.
31. Zarnegar B.J., Wang Y., Mahoney D.J., Dempsey P.W., Cheung H.H., He J., et al. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol 2008, 9:1371-1378.
32. Lee S., Challa-Malladi M., Bratton S.B., Wright C.W. NF-kappaB-inducing kinase (NIK) contains an amino terminal inhibitor of apoptosis (IAP) binding motif (IBM) that potentiates NIK degradation by c-IAP1. J Biol Chem 2014, 289:30680-30689.
33. Burstein E., Ganesh L., Dick R.D., van De Sluis B., Wilkinson J.C., Klomp L.W., et al. A novel role for XIAP in copper homeostasis through regulation of MURR1. EMBO J 2004, 23:244-254.
34. Mufti A.R., Burstein E., Csomos R.A., Graf P.C., Wilkinson J.C., Dick R.D., et al. XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol Cell 2006, 21:775-785.
35. Oberoi T.K., Dogan T., Hocking J.C., Scholz R.P., Mooz J., Anderson C.L., et al. IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation. EMBO J 2012, 31:14-28.
36. Xu L., Zhu J., Hu X., Zhu H., Kim H.T., LaBaer J., et al. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1. Mol Cell 2007, 28:914-922.
37. Maine G.N., Mao X., Muller P.A., Komarck C.M., Klomp L.W., Burstein E. COMMD1 expression is controlled by critical residues that determine XIAP binding. Biochem J 2009, 417:601-609.
38. Mace P.D., Shirley S., Day C.L. Assembling the building blocks: structure and function of inhibitor of apoptosis proteins. Cell Death Differ 2010, 17:46-53.
39. Mace P.D., Smits C., Vaux D.L., Silke J., Day C.L. Asymmetric recruitment of cIAPs by TRAF2. J Mol Biol 2010, 400:8-15.
40. Zheng C., Kabaleeswaran V., Wang Y., Cheng G., Wu H. Crystal structures of the TRAF2:cIAP2 and the TRAF1:TRAF2:cIAP2 complexes: affinity, specificity, and regulation. Mol Cell 2010, 38:101-113.
41. Lu M., Lin S.C., Huang Y., Kang Y.J., Rich R., Lo Y.C., et al. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell 2007, 26:689-702.
42. Vaux D.L., Silke J. IAPs RINGs and ubiquitylation. Nat Rev Mol Cell biol 2005, 6:287-297.
43. MacFarlane M., Merrison W., Bratton S.B., Cohen G.M. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J Biol Chem 2002, 277:36611-36616.
44. Morizane Y., Honda R., Fukami K., Yasuda H. X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. J Biochem 2005, 137:125-132.
45. Choi Y.E., Butterworth M., Malladi S., Duckett C.S., Cohen G.M., Bratton S.B. The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing. J Biol Chem 2009, 284:12772-12782.
46. Huang H., Joazeiro C.A., Bonfoco E., Kamada S., Leverson J.D., Hunter T. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 2000, 275:26661-26664.
47. Hu S., Yang X. Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J Biol Chem 2003, 278:10055-10060.
48. Wilkinson J.C., Wilkinson A.S., Scott F.L., Csomos R.A., Salvesen G.S., Duckett C.S. Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition. J Biol Chem 2004, 279:51082-51090.
49. Budhidarmo R., Nakatani Y., Day C.L. RINGs hold the key to ubiquitin transfer. Trends Biochem Sci 2012, 37:58-65.
50. Metzger M.B., Pruneda J.N., Klevit R.E., Weissman A.M. RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim Biophys Acta 2014, 1843:47-60.
51. Silke J., Kratina T., Chu D., Ekert P.G., Day C.L., Pakusch M., et al. Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc Natl Acad Sci USA 2005, 102:16182-16187.
52. Feltham R., Bettjeman B., Budhidarmo R., Mace P.D., Shirley S., Condon S.M., et al. Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization. J Biol Chem 2011, 286:17015-17028.
53. Mace P.D., Linke K., Feltham R., Schumacher F.R., Smith C.A., Vaux D.L., et al. Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment. J Biol Chem 2008, 283:31633-31640.
54. Dou H., Buetow L., Sibbet G.J., Cameron K., Huang D.T. BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nat Struct Mol Biol 2012, 19:876-883.
55. Linke K., Mace P.D., Smith C.A., Vaux D.L., Silke J., Day C.L. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ 2008, 15:841-848.
56. Plechanovova A., Jaffray E.G., Tatham M.H., Naismith J.H., Hay R.T. Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature 2012, 489:115-120.
57. Nakatani Y., Kleffmann T., Linke K., Condon S.M., Hinds M.G., Day C.L. Regulation of ubiquitin transfer by XIAP, a dimeric RING E3 ligase. Biochem J 2013, 450:629-638.
58. Plechanovova A., Jaffray E.G., McMahon S.A., Johnson K.A., Navratilova I., Naismith J.H., et al. Mechanism of ubiquitylation by dimeric RING ligase RNF4. Nat Struct Mol Biol 2011, 18:1052-1059.
59. Pruneda J.N., Littlefield P.J., Soss S.E., Nordquist K.A., Chazin W.J., Brzovic P.S., et al. Structure of an E3:E2~Ub complex reveals an allosteric mechanism shared among RING/U-box ligases. Mol Cell 2012, 47:933-942.
60. Shi Y. Mechanical aspects of apoptosome assembly. Curr Opin Cell Biol 2006, 18:677-684.
61. Lopez J., John S.W., Tenev T., Rautureau G.J., Hinds M.G., Francalanci F., et al. CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Mol Cell 2011, 42:569-583.
62. Dueber E.C., Schoeffler A.J., Lingel A., Elliott J.M., Fedorova A.V., Giannetti A.M., et al. Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science 2011, 334:376-380.
63. Blankenship J.W., Varfolomeev E., Goncharov T., Fedorova A.V., Kirkpatrick D.S., Izrael-Tomasevic A., et al. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1). Biochem J 2009, 417:149-160.
64. Gyrd-Hansen M., Darding M., Miasari M., Santoro M.M., Zender L., Xue W., et al. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat Cell Biol 2008, 10:1309-1317.
65. Hurley J.H., Lee S., Prag G. Ubiquitin-binding domains. Biochem J 2006, 399:361-372.
66. Budhidarmo R., Day C.L. The ubiquitin-associated domain of cellular inhibitor of apoptosis proteins facilitates ubiquitylation. J Biol Chem 2014, 289:25721-25736.
67. Komander D., Reyes-Turcu F., Licchesi J.D., Odenwaelder P., Wilkinson K.D., Barford D. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep 2009, 10:466-473.
68. Tse M.K., Hui S.K., Yang Y., Yin S.T., Hu H.Y., Zou B., et al. Structural analysis of the UBA domain of X-linked inhibitor of apoptosis protein reveals different surfaces for ubiquitin-binding and self-association. PLoS ONE 2011, 6:e28511.
69. Hofmann K., Bucher P. The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway. Trends Biochem Sci 1996, 21:172-173.
70. Walinda E., Morimoto D., Sugase K., Konuma T., Tochio H., Shirakawa M. Solution structure of the ubiquitin-associated (UBA) domain of human autophagy receptor NBR1 and its interaction with ubiquitin and polyubiquitin. J Biol Chem 2014, 289:13890-13892.
71. Altieri D.C. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 2006, 18:609-615.
72. Lens S.M., Vader G., Medema R.H. The case for Survivin as mitotic regulator. Curr Opin Cell Biol 2006, 18:616-622.
73. Chantalat L., Skoufias D.A., Kleman J.P., Jung B., Dideberg O., Margolis R.L. Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions. Mol Cell 2000, 6:183-189.
74. Verdecia M.A., Huang H., Dutil E., Kaiser D.A., Hunter T., Noel J.P. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol 2000, 7:602-608.
75. Muchmore S.W., Chen J., Jakob C., Zakula D., Matayoshi E.D., Wu W., et al. Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin. Mol Cell 2000, 6:173-182.
76. Sun C., Nettesheim D., Liu Z., Olejniczak E.T. Solution structure of human survivin and its binding interface with Smac/Diablo. Biochemistry 2005, 44:11-17.
77. Ruchaud S., Carmena M., Earnshaw W.C. Chromosomal passengers: conducting cell division. Nat Rev Mol Cell biol 2007, 8:798-812.
78. Sessa F., Mapelli M., Ciferri C., Tarricone C., Areces L.B., Schneider T.R., et al. Mechanism of Aurora B activation by INCENP and inhibition by hesperadin. Mol Cell 2005, 18:379-391.
79. Jeyaprakash A.A., Klein U.R., Lindner D., Ebert J., Nigg E.A., Conti E. Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell 2007, 131:271-285.
80. Bourhis E., Hymowitz S.G., Cochran A.G. The mitotic regulator Survivin binds as a monomer to its functional interactor Borealin. J Biol Chem 2007, 282:35018-35023.
81. Colnaghi R., Connell C.M., Barrett R.M., Wheatley S.P. Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem 2006, 281:33450-33456.
82. Ruchaud S., Carmena M., Earnshaw W.C. The chromosomal passenger complex: one for all and all for one. Cell 2007, 131:230-231.
83. Kelly A.E., Ghenoiu C., Xue J.Z., Zierhut C., Kimura H., Funabiki H. Survivin reads phosphorylated histone H3 threonine 3 to activate the mitotic kinase Aurora B. Science 2010, 330:235-239.
84. Wang F., Dai J., Daum J.R., Niedzialkowska E., Banerjee B., Stukenberg P.T., et al. Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis. Science 2010, 330:231-235.
85. Yamagishi Y., Honda T., Tanno Y., Watanabe Y. Two histone marks establish the inner centromere and chromosome bi-orientation. Science 2010, 330:239-243.
86. Du J., Kelly A.E., Funabiki H., Patel D.J. Structural basis for recognition of H3T3ph and Smac/DIABLO N-terminal peptides by human Survivin. Structure 2012, 20:185-195.
87. Jeyaprakash A.A., Basquin C., Jayachandran U., Conti E. Structural basis for the recognition of phosphorylated histone h3 by the survivin subunit of the chromosomal passenger complex. Structure 2011, 19:1625-1634.
88. Niedzialkowska E., Wang F., Porebski P.J., Minor W., Higgins J.M., Stukenberg P.T. Molecular basis for phosphospecific recognition of histone H3 tails by Survivin paralogues at inner centromeres. Mol Biol Cell 2012, 23:1457-1466.
89. Bartke T., Pohl C., Pyrowolakis G., Jentsch S. Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. Mol Cell 2004, 14:801-811.
90. Hao Y., Sekine K., Kawabata A., Nakamura H., Ishioka T., Ohata H., et al. Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function. Nat Cell Biol 2004, 6:849-860.
91. Sekine K., Hao Y., Suzuki Y., Takahashi R., Tsuruo T., Naito M. HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cells. Biochem Biophys Res Comm 2005, 330:279-285.
92. Wenzel D.M., Stoll K.E., Klevit R.E. E2s: structurally economical and functionally replete. Biochem J 2011, 433:31-42.
93. Sheng Y., Hong J.H., Doherty R., Srikumar T., Shloush J., Avvakumov G.V., et al. A human ubiquitin conjugating enzyme (E2)-HECT E3 ligase structure-function screen. Mol Cell Proteomics 2012, 11:329-341.
94. Maier J.K., Lahoua Z., Gendron N.H., Fetni R., Johnston A., Davoodi J., et al. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci 2002, 22:2035-2043.
95. Davoodi J., Ghahremani M.H., Es-Haghi A., Mohammad-Gholi A., Mackenzie A. Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9. Int J Biochem Cell biol 2010, 42:958-964.
96. Davoodi J., Lin L., Kelly J., Liston P., MacKenzie A.E. Neuronal apoptosis-inhibitory protein does not interact with Smac and requires ATP to bind caspase-9. J Biol Chem 2004, 279:40622-40628.
97. Herman M.D., Moche M., Flodin S., Welin M., Tresaugues L., Johansson I., et al. Structures of BIR domains from human NAIP and cIAP2. Acta Crystallogr F 2009, 65:1091-1096.
98. Karimpour S., Davoodi J., Ghahremani M.H. Integrity of ATP binding site is essential for effective inhibition of the intrinsic apoptosis pathway by NAIP. Biochem Biophys Res Comm 2011, 407:158-162.
99. Lechtenberg B.C., Mace P.D., Riedl S.J. Structural mechanisms in NLR inflammasome signaling. Curr Opin Struct Biol 2014, 29C:17-25.
100. Maltez V.I., Miao E.A. NAIP inflammasomes give the NOD to bacterial ligands. Trends Immunol 2014, 35:503-504.
101. Tenthorey J.L., Kofoed E.M., Daugherty M.D., Malik H.S., Vance R.E. Molecular basis for specific recognition of bacterial ligands by NAIP/NLRC4 inflammasomes. Mol Cell 2014, 54:17-29.
102. Halff E.F., Diebolder C.A., Versteeg M., Schouten A., Brondijk T.H., Huizinga E.G. Formation and structure of a NAIP5-NLRC4 inflammasome induced by direct interactions with conserved N- and C-terminal regions of flagellin. J Biol Chem 2012, 287:38460-38472.
103. Phillips A.H., Schoeffler A.J., Matsui T., Weiss T.M., Blankenship J.W., Zobel K., et al. Internal motions prime cIAP1 for rapid activation. Nat Struct Mol Biol 2014, 21:1068-1074.
104. Nakamura T., Wang L., Wong C.C., Scott F.L., Eckelman B.P., Han X., et al. Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. Mol Cell 2010, 39:184-195.
105. Sims J.J., Haririnia A., Dickinson B.C., Fushman D., Cohen R.E. Avid interactions underlie the Lys63-linked polyubiquitin binding specificities observed for UBA domains. Nat Struct Mol Biol 2009, 16:883-889.
106. Rojas-Fernandez A., Plechanovova A., Hattersley N., Jaffray E., Tatham M.H., Hay R.T. SUMO chain-induced dimerization activates RNF4. Mol Cell 2014, 53:880-892.